Radiotherapy and radioisotope developer Eckert & Ziegler Isotope Products of Berlin has announced that the CEO of its IBt Bebig subsidiary, François Blondel, is leaving the company.
Eckert & Ziegler announced on March 24 that Blondel was resigning and was also giving up his duties as a director of IBt. IBt directors Edgar Löffler and Gunnar Mann have been tapped to oversee the daily management of the company.
As recently as last month, IBt Bebig had been in talks to enter the U.S. market for brachytherapy implants through a merger with its U.S. partner, Core Oncology of Santa Barbara, CA.
Related Reading
Eckert & Ziegler to buy rest of IBt, December 29, 2009
Eckert & Ziegler reports Q3 sales growth, November 5, 2009
Eckert & Ziegler, IBt consolidate brachytherapy units, February 19, 2008
Eckert & Ziegler launch new gallium generator, November 13, 2007
Copyright © 2010 AuntMinnie.com
